Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou No. 1 Pharmaceutical Co., Ltd. is a long-established Chinese pharmaceutical manufacturer specializing in the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. As a core subsidiary of Grand Pharmaceutical Group, the company focuses on anti-infective agents, including a wide range of antibiotics such as penicillins, cephalosporins, and quinolones. The company operates large-scale manufacturing facilities that comply with international GMP standards, enabling it to supply both domestic and global markets. Its product portfolio is primarily centered on mature, essential medicines used to treat respiratory, urinary, and gastrointestinal infections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou No.1 Pharm.